Cutaneous Melanoma Detection and Management

Cutaneous melanoma arises from pigment-producing cells in the skin and, while less common than other skin cancers, accounts for the majority of skin cancer deaths because of its capacity to metastasize early and unpredictably. Accurate diagnosis relies on tools like dermoscopy and, increasingly, deep learning algorithms that can match or exceed specialist performance in distinguishing malignant lesions from benign ones, while sentinel lymph node biopsy remains central to determining how far a tumor has spread and guiding treatment decisions. Recent advances in immunotherapy and targeted treatments for specific genetic alterations—such as mutations in BRAF—have substantially improved survival for patients with advanced disease, though durable responses remain inconsistent and resistance mechanisms are not yet fully understood. Researchers continue to work on refining staging systems, identifying biomarkers that predict treatment response, and understanding the epidemiological forces driving rising incidence rates in certain populations.

Works

102,972

Total citations

1,267,265

Keywords

MelanomaDermoscopySkin CancerSentinel Lymph Node BiopsyGenetic AlterationsImmunotherapy